HIV Alert: Novel Strategies and Agents for HIV Management

Listen to downloadable audio from a series of live Webinars by Daniel R. Kuritzkes, MD, and Paul E. Sax, MD, in which potential future HIV treatment strategies—including long-acting ART, dual-therapy regimens, and investigational agents—are discussed and audience questions on this subject are addressed.
Format: Audio (.mp3)
File Size: 35.40 MB
Released: November 13, 2017

Listen to downloadable audio from a series of live Webinars by Daniel R. Kuritzkes, MD, and Paul E. Sax, MD, in which potential future HIV treatment strategies—including long-acting ART, dual-therapy regimens, and investigational agents—are discussed and audience questions on this subject are addressed. (45 minutes)

Daniel R. Kuritzkes, MD, has disclosed that he has received consulting fees from Gilead Sciences, GlaxoSmithKline, Janssen, Merck, and ViiV and funds for research support from Abbott, Gilead Sciences, and Merck.

Paul E. Sax, MD, has disclosed that he has received consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV, Janssen, and Merck and funds for research support from Bristol-Myers Squibb, Gilead Sciences, and GlaxoSmithKline/ViiV.

Acknowledgements

Educational grant provided by:
ViiV Healthcare

Related Content

CME-certified expert panel discussion on initiating or switching ART in a series of challenging patient cases.

Monica Gandhi, MD, MPH
Program Director
Eric S. Daar, MD Sally Hodder, MD Babafemi Taiwo, MBBS
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.2 Nursing contact hours Pharmacists: 1.25 contact hours (0.13 CEUs) Released: June 15, 2018 Expiration: June 14, 2019

Eric S. Daar, MD
Program Director
Joseph J. Eron, Jr., MD
Program Director
Daniel R. Kuritzkes, MD
Program Director
José R. Arribas, MD
Released: June 13, 2018

Full slides: controversies in PrEP, ART initiation, and HIV treatment choices. From David A. Wohl, MD, Joseph J. Eron, Jr., MD, Princy N. Kumar, MD.

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD
Program Director
David A. Wohl, MD
Released: May 29, 2018

Listen to downloadable audio from a series of live Webinars by Paul E. Sax, MD, and Brian Wood, MD, in which the use of recently approved integrase inhibitor–based regimens is discussed and audience questions on this subject are addressed.

Released: April 23, 2018

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?